| Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines I Litvan, JG Goldman, AI Tröster, BA Schmand, D Weintraub, RC Petersen, ... Movement disorders 27 (3), 349-356, 2012 | 2873 | 2012 |
| Evolution of cognitive dysfunction in an incident Parkinson's disease cohort CH Williams-Gray, T Foltynie, CEG Brayne, TW Robbins, RA Barker Brain 130 (7), 1787-1798, 2007 | 1211 | 2007 |
| The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort CH Williams-Gray, JR Evans, A Goris, T Foltynie, M Ban, TW Robbins, ... Brain 132 (11), 2958-2969, 2009 | 1179 | 2009 |
| Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis D Aarsland, K Bronnick, C Williams-Gray, D Weintraub, K Marder, ... Neurology 75 (12), 1062-1069, 2010 | 1097 | 2010 |
| Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies International Parkinson Disease Genomics Consortium The Lancet 377 (9766), 641-649, 2011 | 1030 | 2011 |
| The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort CH Williams-Gray, SL Mason, JR Evans, T Foltynie, C Brayne, ... Journal of Neurology, Neurosurgery & Psychiatry 84 (11), 1258-1264, 2013 | 764 | 2013 |
| Loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1/Parkin-dependent mitophagy S Lesage, V Drouet, E Majounie, V Deramecourt, M Jacoupy, A Nicolas, ... The American Journal of Human Genetics 98 (3), 500-513, 2016 | 440 | 2016 |
| Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease LA Robak, IE Jansen, J Van Rooij, AG Uitterlinden, R Kraaij, J Jankovic, ... Brain 140 (12), 3191-3203, 2017 | 419 | 2017 |
| Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease A Beilina, IN Rudenko, A Kaganovich, L Civiero, H Chau, SK Kalia, ... Proceedings of the National Academy of Sciences 111 (7), 2626-2631, 2014 | 390 | 2014 |
| Tau and α‐synuclein in susceptibility to, and dementia in, Parkinson's disease A Goris, CH Williams‐Gray, GR Clark, T Foltynie, SJG Lewis, J Brown, ... Annals of neurology 62 (2), 145-153, 2007 | 356 | 2007 |
| Glucocerebrosidase mutations influence the natural history of Parkinson’s disease in a community-based incident cohort SE Winder-Rhodes, JR Evans, M Ban, SL Mason, CH Williams-Gray, ... Brain 136 (2), 392-399, 2013 | 355 | 2013 |
| S erum immune markers and disease progression in an incident P arkinson's disease cohort (ICICLE‐PD) CH Williams‐Gray, R Wijeyekoon, AJ Yarnall, RA Lawson, DP Breen, ... Movement disorders 31 (7), 995-1003, 2016 | 308 | 2016 |
| Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's G Liu, B Boot, JJ Locascio, IE Jansen, S Winder‐Rhodes, S Eberly, ... Annals of neurology 80 (5), 674-685, 2016 | 285 | 2016 |
| The natural history of treated Parkinson's disease in an incident, community based cohort JR Evans, SL Mason, CH Williams-Gray, T Foltynie, C Brayne, ... Journal of Neurology, Neurosurgery & Psychiatry 82 (10), 1112-1118, 2011 | 284 | 2011 |
| Parkinson's disease and dopaminergic therapy—differential effects on movement, reward and cognition JB Rowe, L Hughes, BCP Ghosh, D Eckstein, CH Williams-Gray, S Fallon, ... Brain 131 (8), 2094-2105, 2008 | 263 | 2008 |
| The Cambridge Behavioural Inventory revised HJ Wear, CJ Wedderburn, E Mioshi, CH Williams-Gray, SL Mason, ... Dementia and Neuropsychologia 2 (2), 102-107, 2008 | 256 | 2008 |
| The pathogenesis of Parkinson's disease HR Morris, MG Spillantini, CM Sue, CH Williams-Gray The Lancet 403 (10423), 293-304, 2024 | 252 | 2024 |
| Cognitive decline and quality of life in incident Parkinson's disease: the role of attention RA Lawson, AJ Yarnall, GW Duncan, DP Breen, TK Khoo, ... Parkinsonism & related disorders 27, 47-53, 2016 | 244 | 2016 |
| The clinical heterogeneity of Parkinson's disease and its therapeutic implications JC Greenland, CH Williams‐Gray, RA Barker European Journal of Neuroscience 49 (3), 328-338, 2019 | 232 | 2019 |
| Cognitive deficits and psychosis in Parkinson’s disease: a review of pathophysiology and therapeutic options CH Williams-Gray, T Foltynie, SJG Lewis, RA Barker CNS drugs 20, 477-505, 2006 | 230 | 2006 |